Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy
- 4 April 2013
- journal article
- chest
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 23 (8), 2127-2136
- https://doi.org/10.1007/s00330-013-2821-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Non–Small Cell Lung Cancer: Detection of Early Response to Chemotherapy by Using Contrast-enhanced Dynamic and Diffusion-weighted MR ImagingRadiology, 2011
- Whole-Tumor Perfusion CT in Patients with Advanced Lung Adenocarcinoma Treated with Conventional and Antiangiogenetic Chemotherapy: Initial ExperienceRadiology, 2011
- Assessment of Non–Small Cell Lung Cancer Perfusion: Pathologic-CT Correlation in 15 PatientsRadiology, 2010
- Perfusion MDCT Enables Early Detection of Therapeutic Response to Antiangiogenic TherapyAmerican Journal of Roentgenology, 2008
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Quantitative Assessment of Lung Cancer Perfusion Using MDCT: Does Measurement Reproducibility Improve with Greater Tumor Volume Coverage?American Journal of Roentgenology, 2006
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerNature Medicine, 2004
- Lung Tumors Evaluated With FDG-PET and Dynamic CT: The Relationship Between Vascular Density and Glucose MetabolismJournal of Computer Assisted Tomography, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000